Pricing Log in Create free account

Curis, Inc. (CRIS) vs Soligenix Inc. (SNGX)

Curis, Inc. and Soligenix Inc. are both Biotechnology companies. Soligenix Inc. is the larger, with a market value of $7.3M against $5.7M — 1.3× the size. Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −50.4%. Across the 14 metrics below, Curis, Inc. leads on 8 and Soligenix Inc. on 6.

Valuation

Metric CRIS SNGX Biotechnology median
P/E n/m n/m 10.26
P/S 0.20 10.97 9.18
P/B 0.40 0.82 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.29 0.18 0.65
EV/Sales (0.27) (4.05) 8.98
Earnings yield (1,634.48%) (372.59%) (34.89%)
Free cash flow yield (1,668.41%) (179.73%) (24.52%)

Profitability

Metric CRIS SNGX Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (241.65%) (50.12%)
Return on assets (87.76%) (125.95%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS SNGX Biotechnology median
Revenue growth (TTM) (13.43%) (50.37%) 6.26%
EPS growth (last fiscal year) 91.57% 57.03% 29.88%
Revenue growth, 5-year CAGR (2.71%) (51.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 2.77 4.89
Net debt to EBITDA 0.91 0.67 1.01

Dividend

Metric CRIS SNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRIS SNGX Biotechnology median
Market cap 5.67m 7.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack